1. Home
  2. SYNX vs ASBP Comparison

SYNX vs ASBP Comparison

Compare SYNX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silynxcom Ltd.

SYNX

Silynxcom Ltd.

N/A

Current Price

$1.23

Market Cap

7.1M

Sector

N/A

ML Signal

N/A

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$1.13

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYNX
ASBP
Founded
2005
2021
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
7.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SYNX
ASBP
Price
$1.23
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.3M
219.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$32.35
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.05
52 Week High
$4.55
$2.45

Technical Indicators

Market Signals
Indicator
SYNX
ASBP
Relative Strength Index (RSI) 55.93 42.31
Support Level $0.90 $0.31
Resistance Level $1.31 $1.61
Average True Range (ATR) 0.17 0.13
MACD 0.02 -0.05
Stochastic Oscillator 31.25 3.09

Price Performance

Historical Comparison
SYNX
ASBP

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: